CHICAGO EQUITY PARTNERS LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 213 filers reported holding IMMUNOGEN INC in Q3 2018. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHICAGO EQUITY PARTNERS LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q4 2019$437,000
+41.9%
85,660
-32.7%
0.02%
+66.7%
Q3 2019$308,000
-35.0%
127,305
+154.6%
0.02%
+7.1%
Q3 2018$474,000
-90.7%
50,006
-90.5%
0.01%
-91.1%
Q2 2018$5,124,000
-3.3%
526,660
+4.5%
0.16%
-7.1%
Q1 2018$5,300,000
+69.1%
503,765
+3.0%
0.17%
+76.0%
Q4 2017$3,135,000
-16.5%
489,035
-0.3%
0.10%
-19.3%
Q3 2017$3,753,000
+141.8%
490,635
+124.7%
0.12%
+183.3%
Q2 2017$1,552,000218,3200.04%
Other shareholders
IMMUNOGEN INC shareholders Q3 2018
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders